Patents by Inventor Steven Eugene Dunlap

Steven Eugene Dunlap has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Processes and intermediates useful to make antifolates
    Patent number: 6426417
    Abstract: The present invention concerns intermediates, and processes directed to and from those intermediates, to a series of pyrimidine derivatives of formula (V), which are intermediates to useful antifolate compounds or are themselves useful antifolate compounds.
    Type: Grant
    Filed: August 2, 2000
    Date of Patent: July 30, 2002
    Assignee: Eli Lilly and Company
    Inventors: Charles Jackson Barnett, Steven Eugene Dunlap, Michael Edward Kobierski, John Arnold Werner
  • Anti-viral compounds
    Patent number: 6114327
    Abstract: The present application provides a series of benzimidazole compounds of formula I: ##STR1## which inhibit the growth of picornaviruses, such as rhinoviruses (bovine and human), enteroviruses such as polioviruses, coxsackieviruses of the A and B groups, or echo virus, cardioviruses such as encephalomyocarditis (EMC), apthoviruses such as foot and mouth disease virus, and flaviviruses such as hepatitis C virus and bovine viral diarrhea virus.Such compounds are also useful as intermediates for preparing additional benzimidazole antiviral compounds.
    Type: Grant
    Filed: October 22, 1999
    Date of Patent: September 5, 2000
    Assignee: Eli Lilly and Company
    Inventors: Steven Eugene Dunlap, Louis Nickolaus Jungheim, Mark Joseph Tebbe, Gilbert Thomas Voy, John Arnold Werner